Walgreens Co: (NYSE: WAG)

$49.59

0.52 (1.06%)

Volume 5,411,716

May 14 04:02 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Full Company Report

Get Full Company Report for:

Walgreen Co. is a national retail pharmacy chain and considered the leader in innovative drugstore retailing. Walgreens pioneered many store features that are becoming standards in the industry. Among those concepts are: Computerized pharmacies, Point-of-sale scanning, Freestanding stores with drive-thru pharmacies, and Intercom Plus, Walgreens advanced new pharmacy computer and workflow system. Intercom Plus allows pharmacists to spend more time counseling patients by assigning administrative tasks to pharmacy technicians

General Information

WALGREEN CO
108 WILMOT RD
DEERFIELD, IL 60015
Phone: 8479402500
Fax: 847-914-2804
Web: http://www.walgreens.com
Email: investor.relations@walgreens.com

Industry RETAIL-DRUG STR
Sector Retail-Wholesale
Fiscal Year End August
Last Reported Quarter 02/28/2013
Next EPS Date 06/25/2013

Price and Volume Information

Zacks Rank
Yesterday's Close 49.07
52 Week High 50.35
52 Week Low 28.53
Beta 1.07
20 Day Moving Average 5,503,789.00
Target Price Consensus 46.69

% Price Change

4 Week 1.08
12 Week 18.92
YTD 32.59

Share Information

Shares Outstanding (millions) 947.48
Market Capitalization (millions) 46,985.79
Short Ratio 1.78
Last Split Date 02/16/99

WAG

% Price Change Relative to S&P 500

4 Week -3.56
12 Week 10.32
YTD 14.92

Dividend Information

Dividend Yield 2.22%
Annual Dividend $1.10
Payout Ratio 0.41
Change in Payout Ratio 0.11
Last Dividend Payout / Amount 02/13/2013 / $0.28

EPS Information

Current Quarter EPS Consensus Estimate 0.90
Current Year EPS Consensus Estimate 3.27
Estimated Long-Term EPS Growth Rate 12.50
Next EPS Report Date 06/25/2013

Consensus Recommendations

Current (1=Strong Buy, 5=Strong Sell) 1.88
30 Days Ago 1.88
60 Days Ago 2.06
90 Days Ago 2.11

Fundamental Ratios

P/E

Current FY Estimate 15.18
Trailing 12 Months 18.43
PEG Ratio 1.22

Price Ratios

Price/Book 2.47
Price/Cash Flow 13.21
Price / Sales 0.66

Current Ratio

02-28-13 1.38
11-30-12 1.30
08-31-12 1.23

Net Margin

02-28-13 2.91
11-30-12 2.81
08-31-12 2.97

Inventory Turnover

02-28-13 6.90
11-30-12 6.91
08-31-12 6.93

EPS Growth

vs. Previous Year 23.08%
vs. Previous Quarter 65.52%
   

ROE

02-28-13 14.01
11-30-12 13.49
08-31-12 14.29

Quick Ratio

02-28-13 0.57
11-30-12 0.47
08-31-12 0.43

Pre-Tax Margin

02-28-13 4.61
11-30-12 4.47
08-31-12 4.71

Debt-to-Equity

02-28-13 0.27
11-30-12 0.28
08-31-12 0.22

Sales Growth

vs. Previous Year -0.02%
vs. Previous Quarter 7.69%
   

ROA

02-28-13 7.52
11-30-12 7.32
08-31-12 7.82

Operating Margin

02-28-13 3.49
11-30-12 3.17
08-31-12 3.13

Book Value

02-28-13 20.08
11-30-12 19.43
08-31-12 19.36

Debt to Capital

02-28-13 21.05
11-30-12 21.62
08-31-12 18.26

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.